Drug-induced resistance evolution necessitates less aggressive treatment.

Abstract excerpt

Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified and included to the evolutionarily informed treatment protocol. Here we identify, characterise and exploit a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Infective Agents
• Share to Computer Simulation